SOLIGO, DAVIDE
 Distribuzione geografica
Continente #
EU - Europa 6.347
NA - Nord America 5.229
AS - Asia 4.751
SA - Sud America 354
AF - Africa 113
OC - Oceania 20
Continente sconosciuto - Info sul continente non disponibili 17
Totale 16.831
Nazione #
US - Stati Uniti d'America 5.077
GB - Regno Unito 2.327
CN - Cina 1.699
SG - Singapore 1.371
IT - Italia 778
DE - Germania 721
SE - Svezia 661
RU - Federazione Russa 560
UA - Ucraina 379
HK - Hong Kong 355
VN - Vietnam 273
IN - India 259
FR - Francia 238
TR - Turchia 230
BR - Brasile 209
KR - Corea 202
NL - Olanda 177
EU - Europa 173
IE - Irlanda 162
FI - Finlandia 133
CA - Canada 105
BD - Bangladesh 100
CO - Colombia 85
JP - Giappone 69
GR - Grecia 58
CI - Costa d'Avorio 47
BE - Belgio 37
ID - Indonesia 37
UZ - Uzbekistan 25
DK - Danimarca 24
AR - Argentina 23
PL - Polonia 21
AU - Australia 17
PK - Pakistan 17
AT - Austria 16
IQ - Iraq 16
ES - Italia 14
IR - Iran 13
MX - Messico 13
SA - Arabia Saudita 12
PH - Filippine 11
KE - Kenya 10
ZA - Sudafrica 10
CR - Costa Rica 9
MA - Marocco 9
CZ - Repubblica Ceca 8
PE - Perù 8
AE - Emirati Arabi Uniti 7
EC - Ecuador 7
TW - Taiwan 7
VE - Venezuela 7
EG - Egitto 6
MY - Malesia 6
TH - Thailandia 6
HN - Honduras 5
LB - Libano 5
PT - Portogallo 5
QA - Qatar 5
TN - Tunisia 5
AZ - Azerbaigian 4
GT - Guatemala 4
JM - Giamaica 4
PA - Panama 4
PY - Paraguay 4
RO - Romania 4
UY - Uruguay 4
BH - Bahrain 3
BO - Bolivia 3
CD - Congo 3
CL - Cile 3
DZ - Algeria 3
IL - Israele 3
JO - Giordania 3
KZ - Kazakistan 3
NZ - Nuova Zelanda 3
RS - Serbia 3
AL - Albania 2
GH - Ghana 2
GL - Groenlandia 2
HU - Ungheria 2
LA - Repubblica Popolare Democratica del Laos 2
LT - Lituania 2
LU - Lussemburgo 2
MO - Macao, regione amministrativa speciale della Cina 2
NG - Nigeria 2
NO - Norvegia 2
OM - Oman 2
PR - Porto Rico 2
SK - Slovacchia (Repubblica Slovacca) 2
SO - Somalia 2
TT - Trinidad e Tobago 2
UG - Uganda 2
BA - Bosnia-Erzegovina 1
BF - Burkina Faso 1
BG - Bulgaria 1
BY - Bielorussia 1
CG - Congo 1
CH - Svizzera 1
CM - Camerun 1
CW - ???statistics.table.value.countryCode.CW??? 1
Totale 16.967
Città #
Southend 2.116
Singapore 782
Ashburn 536
Beijing 391
Jacksonville 361
Chandler 356
Hong Kong 339
Seattle 301
San Jose 290
Princeton 224
Ann Arbor 212
Wilmington 202
Milan 188
Dallas 185
Dublin 159
Redmond 149
Council Bluffs 142
Bengaluru 136
Nanjing 128
Los Angeles 124
Santa Clara 120
Serra 113
Frankfurt am Main 102
Andover 99
Sakarya 96
Somerville 88
Berlin 87
Lauterbourg 87
Dearborn 86
Boardman 83
Bogotá 83
Hefei 83
Ho Chi Minh City 79
Toronto 76
Mountain View 73
Shanghai 72
Des Moines 69
Woodbridge 69
New York 67
Moscow 64
Hanoi 63
Buffalo 62
Fairfield 62
Athens 58
Houston 58
Saint Petersburg 58
Shenyang 47
Abidjan 46
Jinan 43
Guangzhou 42
Pisa 41
Tianjin 41
Cangzhou 40
Nanchang 38
Columbus 35
Tokyo 33
Bitonto 31
Munich 31
Helsinki 29
Brussels 28
Changsha 27
Rome 25
Hebei 23
São Paulo 23
Grafing 20
The Dalles 20
Zhengzhou 20
Jakarta 19
Redwood City 18
Verona 18
Hangzhou 17
Chicago 16
Dong Ket 16
Düsseldorf 15
Fuzhou 15
Kunming 15
Warsaw 15
Auburn Hills 14
Kiez 14
Phoenix 14
Cambridge 13
Margão 13
Mumbai 13
San Diego 13
Hanover 12
Istanbul 12
Orem 12
Da Nang 11
Lanzhou 11
Montreal 11
Naples 11
Washington 11
Wuhan 11
Jiaxing 10
Ningbo 10
Quanzhou 10
Roxbury 10
Shenzhen 10
Turin 10
Vienna 10
Totale 10.491
Nome #
RAS mutations vontribute to evolution of chronic myelomonocytic leukemia to the proliferative variant 464
Primary cutaneous gamma/delta T-cell lymphoma presenting as disseminated pagetoid reticulosis 351
Istiocitosi a cellule indeterminate con evoluzione in leucemia mieloide acuta: caso clinico 339
Induction of neurotrophin expression via human adult mesenchymal stem cells : implication for cell therapy in neurodegenerative diseases 304
Bone marrow endothelial progenitors in Systemic Sclerosis : evidence for apoptotic phenotype and correlation with anti-endothelial cell antibodies 269
Bone marrow endothelial progenitors are defective in systemic sclerosis 267
Bone marrow monocytes in histiocytosis X acquire some phenotypic features of Langerhans cells in long term bone marrow cultures 259
G-CSF after autologous hemopoietic stem cell transplantation in malignant lymphoma 239
Multilineage potential of human amniotic fluid cells 237
Human bone marrow mesenchymal stem cells transplantation in 6-hydroxydopamine-lesioned rodents 231
A long-term follow-up analysis in adult acute myeloid leukemia patients after hematopoietic stem cell transplantation 228
Systemic Sclerosis and fibrosis : a new role for bone marrow mesenchymal stem cells 224
Unrelated bone marrow transplantation with reduced-intensity regimen in high-risk patients for age or disease: a prospective GITMO study 222
Abnormal neutrophil chemotaxis in bone marrow transplant patients correlates with impaired 31D8 monoclonal antibody binding. 220
Neuroprotective potential of human mesenchymal stem cells in a rodent model of Parkinson's disese 218
Indeterminate cell histiocytosis in association with later occurrence of acute myeloblastic leukaemia 214
Transdermal fentanyl in HSCT patients : an open trial using transdermal fentanyl for the treatment of oral mucositis pain 211
Incidence and predictive factors of hepatic veno-occlusive disease after bone marrow transplantation 210
Transdermal estradiol in haemorrhagic cystitis after allogeneic haematopoietic stem transplantation 209
Skeletal muscle differentiation potential of human adult bone marrow cells 208
Bone marrow and tissue expression of gpIIb/IIIa, LFA-1, Mac-1 and gp 150,95 glycoproteins 205
Bone marrow histology and CD34 immunostaining in the prognostic evaluation of primary myelodysplastic syndromes 204
Unrelated mismatched cord blood transplantation in an adult with secondary AML 203
Histological alterations in bone marrow in patients with late engraftment after autologous bone marrow transplantation 198
In vitro effects of IL-2 on NK activity, clonogenic potential, blast cell proliferation and cytokine release of MDS bone marrow patients 198
Squamous cell carcinoma of the oral cavity associated with graft versus host disease : report of a case and review of the literature 197
Sphingosine Kinase 1 is involved in survival and proliferation of myeloid leukemia cells, representing a potential novel target for treatment 193
Abnormal neutrophil chemotaxis after successful bone marrow transplantation. 191
In vitro and In Vivo mesenchymal stem cells neurothrophin production but limited neuronal differantiation 188
Human mesenchymal stem cell implant in a rodent Parkinson's model : preliminary results from an in vitro and in vivo study 186
Prophylaxis and therapy in febrile neutropenia after haematopoietic stem cell transplantation 185
Reduced intensity conditioning allogeneic transplant for advanced chronic lymphocytic leukemia 185
Involvement of RAS, JAK2 and GM-CSF in the pathogenesis of proliferative variant of chronic myelomonocytic leukaemia 183
Reduced-intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplantation Represents a Feasible and Effective Treatment Strategy for Advanced Mycosis Fungoides and Sezary Syndrome 183
Molecular and phenotypic characterization of human amniotic fluid cells and their differentiation potential 182
Hepatitis B virus reverse seroconversion in allogeneic hematopoietic stem cell transplantation 181
Mesenchymal stem cell as a tool for cell theraphy in a rodent model of Parkinson's disease (6-hydroxydopamine-induced neuronal lesion): an in vitro characterization and toxicity study 181
Sensitivity of human multiple myelomas and myeloid leukemias to the proteasome inhibitor I. 178
Human adult mesenchymal stem cell neuroprotective potential to support neurons' survival 178
Hematopoietic stem cell transplantation in adult acute lymphoblastic leukemia : a single-centre analysis 178
In vitro colony growth, RAS sequencing, and expression of Bcl-2 and Bax proteins in Chronic Myelomonocytic Leukemia 175
Molecular and phenotypical characterization of human amniotic fluid cells and their differentiation potential 174
Neuroprotective potential of human mesenchymal stem cells in a rodent model of Parkinson's disease 173
CMP purification of CD133+ cells from bone marrow and mobilised peripheral blood for intracoronary administration in acute myocardial infarction 172
Acquisition of a RAS point mutation in a patients with chronic myelomonocytic leukemia after progression from dysplastic to proliferative variant 172
Clinical and laboratory findings in a new case of leukocyte adhesion deficiency 172
Defective granulocyte chemotaxis and natural killer activity in a patient with recurrent infections 172
The apoptogenic response of human myeloid leukaemia cell lines and of normal and malignant haematopoietic progenitor cells to the proteasome inhibitor PSI 171
Human adult mesenchymal stem cells potential in a Parkinsonian animal model 171
Oral chronic graft-versus-host disease following allogeneic conventional myeloablative versus non-myeloablative stem cell transplantation 169
Successful surgical treatment of fungal sinusitis in onco-hematological patients 167
Ultrastructural features of CD34+ hematopoietic progenitor cells from bone marrow, peripheral blood and umbilical cord blood 166
Clinical and histopathological features of oral chronic graft-versus-host disease following allogeneic reduced-intensity conditioning haematopoietic stem cell transplantation : a single centre blind study 164
Clinical, biological and molecular characterization of a PNH patient following allogeneic bone marrow transplantation 163
A case of chronic mylomonocytic leukemia progressing from dysplastic to proliferative phenotype after acquisition of a RAS point mutation 163
Sphingosine kinase 1 is involved in proliferation and survival of chronic myeloid leukemia cells 163
Response of myelodysplastic syndrome marrow progenitor cell to stimulation with cytokine combinations in a stroma -free long-term culture system 163
Identification of Actinobacillus actinomycetemcomitans by gold immunolabeling and scanning electron microscopy 159
Efficacy of high-dose N-acetylcysteine in acute GVHD prophylaxis 158
Immunological and molecular characterization of a PNH patient following allogeneic BMT 154
Neuro-glial differentiation of human bone marrow stem cells in vitro 154
Zap-70 on bone marrow biopsy is a good prognostic indicator in B-CLL 154
Hematological, molecular and cytokine changes after reduced intensity bone marrow transplantation for paroxysmal nocturnal hemoglobinuria 153
The impairment of vasculogenesis in systemic sclerosis (SSC) is associated with detective characteristics in bone marrow stem cells 153
GM-CSF receptor as a possible marker to distinguish proliferative and dysplastic variants of chronic myelomonocytic leukemia 152
Unrelated mismatched cord blood transplantation in an adult patient with secondary AML 151
Multiple autoimmune events after autologous bone marrow transplantation 151
The diagnostic and prognostic value of bone marrow immunostaining in myelodysplastic syndromes 151
Intracytoplasmic concentration of GM-CSF and intensity of the GM-CSF membrane receptor are significantly higher in proliferative than in dysplastic variant of CMML and could explain the higher in vivo and in vitro growth pattern 150
Effect of dioxin on normal and leukemic human hematopoietic cells 148
Oral malignancies following HSCT : graft versus host disease and other risk factors 148
Mesenchymal stem cells and 6-hydroxydopamine-induced neuronal lesion: preliminary results of an in vitro and vivo study 147
High rates of hepatitis B virus riverse seroconversion in anti-HBc carriers undergoing allogeneic bone marrow transplantation 146
Clinical and histopathological features of oral chronic graft-versus-host disease following allogenic reduced-intensity conditioning haematopoietic stem cell transplantation: a single-centre blind study 146
Functional differences between dendritic cells derived from CD34+ bone marrow and peripheral blood stem cells 145
Vascular endothelial growth factor activity on mesenchymal stem cell during trans-differentiation towards neural phenotype : a possible link between neurogenesis and angigenesis 144
C60 human bone marrow mesenchimal cell-derived astrocytes : a neuroprotective approach to ALS 144
Analysis of hematopoietic progenitor cells in ALS patients 144
In vitro growth and immunophenotypic characterization of circulating cells from patients with chronic myelomonocytic leukemia 143
Allogeic bone marrow transplantation in a PNH patient : immunological and molecular characterization 142
Treatment of Severe Systemic Sclerosis (SSC) with autologous Haematopoietic Stem Cell Transplantation (HSCT): description of two cases 137
Efficient retrovirus-mediated transduction of primitive human peripheral blood progenitor cells in stroma-free suspension culture 133
Differentiation and expansion of endothelial cells from human bone marrow CD133(+) cells 131
Haematopoietic abnormalities after autologous stem cell transplantation in lymphoma patients 131
In Vitro Characterization of Peripheral Blood Mononuclear Cells and Serum Quantitative Determination of TNF-α, GM-CSF, and MIP-1α Concentrations in Patients with Chronic Myelomonocytic Leukemia 130
Stem cell defects in systemic sclerosis. 127
In vitro effect of clozapine on hemopoietic progenitor cells 127
Neural differentation potential of mesenchymal stem cells and neurotrophin production 126
Bone marrow disseminated tumor cells in patients with carcinoma of the esophagus or cardia 126
Histological parameters and "in vitro" cultures identify different subsets of myelofibrosis with myeloid mataplasia (MMM) 125
Myelodysplastic syndromes after autologous stem cell transplantation 122
Neurogenesis and angiogenesis factors during mesenchymal stem cells trans-differentiation towards neural phenotypes 121
Expansion of dendritic cells derived from human CD34+ cells in static and continuous perfusion cultures 121
Evaluation of coping and compliance in onco-hematological patients 118
Immunological, molecular and cytokine changes after reduced intensity bone marrow transplantation for PNH : a 2 yers follow-up 116
Evidenza di vasculogenesi difettiva in corso di sclerosi sistemica 108
Prospective evaluation of transdermal fentanyl in symptomatic treatment of oral mucositis in patient undergoing bone marrow transplantation 102
Prognostic factors in primary cutaneous B-cell lymphoma: the Italian Study Group for Cutaneous Lymphomas 98
Hepatitis B virus reverse seroconversion in allogeneic hematopoietic stem cell transplantation 91
Indeterminate cell histiocytosis evolving into acute myelogenous leukaemia 89
Totale 17.587
Categoria #
all - tutte 41.768
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 41.768


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202179 0 0 0 0 0 0 0 0 0 0 0 79
2021/2022967 78 27 21 42 57 57 122 58 136 90 86 193
2022/20231.368 179 116 108 143 193 278 37 87 131 14 51 31
2023/2024913 22 67 40 38 197 113 41 113 26 37 96 123
2024/20252.120 86 200 43 222 157 74 44 225 100 155 227 587
2025/20263.980 414 342 358 331 402 314 399 243 453 425 249 50
Totale 17.746